MedTrace Logo

Neurofeedback Therapy for Children Diagnosed With Autism

NCT02773303 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2018-07-24

No results posted yet for this study

Summary

This project aims:

* to further explore the effectiveness of a novel sonified Neurofeedback management therapy for children diagnosed with Autism Spectrum Disorder (ASD)
* to determine if balance control is different before and after therapy

Conditions

Interventions

DEVICE

Mente Autism™

A portable headband records EEG activity, and specialized algorithms convert the EEG activity into sonified binaural signals feeding them back to the user

DEVICE

Sham

a device externally identical to Mente Autism™, providing binaural beats but not tailor-made neurofeedback binaural beats

Sponsors & Collaborators

  • Carrick Institute for Graduate Studies

    lead OTHER

Principal Investigators

  • Frederick R Carrick, PhD · Carrick Institute for Graduate Studies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-12-13
Completion
2017-12-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02773303 on ClinicalTrials.gov